| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.047 | 0.8 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.029 | 0.8 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.0097 | 0.8 |